S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine

S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine

Pegaspargase combined with gemcitabine have greatly improved the outcomes of advanced extranodal NK/T cell lymphoma (ENKL). However, patients frequently undergo recurrent disease due to chemoresistance, and few predictive parameters are available. The present study explored potential biomarkers to p...

Full description

Bibliographic Details
Main Authors: Zhou, Zhiyuan, Li, Zhaoming, Sun, Zhenchang, Zhang, Xudong, Lu, Lisha, Wang, Yingjun, Zhang, Mingzhi
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810364/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810364/

Similar Items